The Safety and Effects of the Beta-Blocker, Nadolol, in Mild Asthma; An Open-label Pilot Study

Beta-blockers are currently contraindicated in asthma because their acute administration may be associated with worsening bronchospasm. However, their effects and safety with their chronic administration are not well evaluated. The rationale for this pilot study was based on the paradigm shift that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hanania, Nicola A, Singh, Supria, Eli-Wali, Rami, Flashner, Michael, Franklin, Amie E, Garner, William J, Dickey, Burton F, Parra, Sergio, Ruoss, Stephen J, Shardonofsky, Felix, O'Connor, Brian J, Page, Clive, Bond, Richard A
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2254137/
https://ncbi.nlm.nih.gov/pubmed/17703976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pupt.2007.07.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados